These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 38003288)

  • 1. A Strategy Utilizing Protein-Protein Interaction Hubs for the Treatment of Cancer Diseases.
    Carels N; Sgariglia D; Junior MGV; Lima CR; Carneiro FRG; Silva GFD; Silva FABD; Scardini R; Tuszynski JA; Andrade CV; Monteiro AC; Martins MG; Silva TGD; Ferraz H; Finotelli PV; Balbino TA; Pinto JC
    Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A computational strategy to select optimized protein targets for drug development toward the control of cancer diseases.
    Carels N; Tilli T; Tuszynski JA
    PLoS One; 2015; 10(1):e0115054. PubMed ID: 25625699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Validation of a network-based strategy for the optimization of combinatorial target selection in breast cancer therapy: siRNA knockdown of network targets in MDA-MB-231 cells as an in vitro model for inhibition of tumor development.
    Tilli TM; Carels N; Tuszynski JA; Pasdar M
    Oncotarget; 2016 Sep; 7(39):63189-63203. PubMed ID: 27527857
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hubba: hub objects analyzer--a framework of interactome hubs identification for network biology.
    Lin CY; Chin CH; Wu HH; Chen SH; Ho CW; Ko MT
    Nucleic Acids Res; 2008 Jul; 36(Web Server issue):W438-43. PubMed ID: 18503085
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer-related networks: a help to understand, predict and change malignant transformation.
    Csermely P; Korcsmáros T
    Semin Cancer Biol; 2013 Aug; 23(4):209-12. PubMed ID: 23831276
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Total network controllability analysis discovers explainable drugs for Covid-19 treatment.
    Wei X; Pan C; Zhang X; Zhang W
    Biol Direct; 2023 Sep; 18(1):55. PubMed ID: 37670359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are protein hubs faster folders? Exploration based on Escherichia coli proteome.
    Xu HR; Cheng JF; Hu XP; Chu YY; Ma BG
    Amino Acids; 2016 Dec; 48(12):2747-2753. PubMed ID: 27515434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Total controllability analysis discovers explainable drugs for Covid-19 treatment.
    Wei X; Pan C; Zhang X; Zhang W
    ArXiv; 2023 Jun; ():. PubMed ID: 35677421
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for dynamically organized modularity in the yeast protein-protein interaction network.
    Han JD; Bertin N; Hao T; Goldberg DS; Berriz GF; Zhang LV; Dupuy D; Walhout AJ; Cusick ME; Roth FP; Vidal M
    Nature; 2004 Jul; 430(6995):88-93. PubMed ID: 15190252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of functional hubs and modules by converting interactome networks into hierarchical ordering of proteins.
    Cho YR; Zhang A
    BMC Bioinformatics; 2010 Apr; 11 Suppl 3(Suppl 3):S3. PubMed ID: 20438650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Exploring the relationship between hub proteins and drug targets based on GO and intrinsic disorder.
    Fu Y; Guo Y; Wang Y; Luo J; Pu X; Li M; Zhang Z
    Comput Biol Chem; 2015 Jun; 56():41-8. PubMed ID: 25854804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting protein-protein interactions as an anticancer strategy.
    Ivanov AA; Khuri FR; Fu H
    Trends Pharmacol Sci; 2013 Jul; 34(7):393-400. PubMed ID: 23725674
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total network controllability analysis discovers explainable drugs for Covid-19 treatment.
    Wei X; Pan C; Zhang X; Zhang W
    Res Sq; 2023 Jul; ():. PubMed ID: 37503262
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dynamic modular architecture of protein-protein interaction networks beyond the dichotomy of 'date' and 'party' hubs.
    Chang X; Xu T; Li Y; Wang K
    Sci Rep; 2013; 3():1691. PubMed ID: 23603706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling Complexity Measured by Shannon Entropy and Its Application in Personalized Medicine.
    Conforte AJ; Tuszynski JA; da Silva FAB; Carels N
    Front Genet; 2019; 10():930. PubMed ID: 31695721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential variation patterns between hubs and bottlenecks in human protein-protein interaction networks.
    Pang E; Hao Y; Sun Y; Lin K
    BMC Evol Biol; 2016 Dec; 16(1):260. PubMed ID: 27903259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative network mapping of the human kinome interactome reveals new clues for rational kinase inhibitor discovery and individualized cancer therapy.
    Cheng F; Jia P; Wang Q; Zhao Z
    Oncotarget; 2014 Jun; 5(11):3697-710. PubMed ID: 25003367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of genomic features with dynamic modularity in the yeast interactome: a view from the structural perspective.
    Wang H; Zheng H
    IEEE Trans Nanobioscience; 2012 Sep; 11(3):244-50. PubMed ID: 22987130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of mRNA and non-coding RNA hubs using network analysis in organ tropism regulated triple negative breast cancer metastasis.
    Banerjee S; Kalyani Yabalooru SR; Karunagaran D
    Comput Biol Med; 2020 Dec; 127():104076. PubMed ID: 33126129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.